Steven J. Pully's most recent trade in Enzo Biochem, Inc. was a trade of 142,897 Common Stock done . Disclosure was reported to the exchange on Jan. 16, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Enzo Biochem, Inc. | Steven J. Pully | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 142,897 | 239,992 (0%) | 0% | 0 | Common Stock | |
RumbleON Inc - Ordinary Sh... | Steven J. Pully | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2024 | 81,561 | 0 | - | - | Subscription Rights (right to buy) | |
RumbleON Inc - Ordinary Sh... | Steven J. Pully | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.18 per share. | 12 Dec 2024 | 5,521 | 115,613 (0%) | 0% | 4.2 | 23,078 | Class B Common Stock |
RumbleON Inc - Ordinary Sh... | Steven J. Pully | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 28,531 | 110,092 (0%) | 0% | - | Class B Common Stock | |
RumbleON Inc - Ordinary Sh... | Steven J. Pully | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 6,838 | 81,561 (0%) | 0% | - | Class B Common Stock | |
Enzo Biochem, Inc. | Steven J. Pully | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 79,365 | 97,095 (0%) | 0% | 0 | Common Stock | |
RumbleON Inc - Ordinary Sh... | Steven Pully J. | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. | 05 Dec 2023 | 27,359 | 74,723 (0%) | 0% | 5.5 | 150,475 | Class B Common Stock |
RumbleON Inc - Ordinary Sh... | Pully Steven J. | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 25,370 | 0 | - | - | Subscription Rights (right to buy) | |
Enzo Biochem, Inc. | Pully Steven J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Oct 2023 | 17,730 | 17,730 (0%) | 0% | 0 | Common Stock | |
RumbleON Inc - Ordinary Sh... | Steven J. Pully | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 45,844 | 47,364 (0%) | 0% | - | Class B Common Stock | |
RumbleON Inc - Ordinary Sh... | Steven J. Pully | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 1,520 | 1,520 (0%) | 0% | - | Class B Common Stock |